Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • To the point

Don’t get angry!

    • News
    • Prevention and health care
    • RX
  • 2 minute read

In the last “Chränzli”, my colleagues once again let off a lot of steam.

Then a physician reported the following annoyance: One of his patients has been suffering from chronic constipation for years. The colleague repeatedly prescribes the troubled man a drug that regulates bowel activity. After a few weeks, he receives mail from his trusted medical colleague. The latter informs him that there is a limit for the prescribed medication and that he should please answer the enclosed questions so that the obligation to pay benefits can be checked. Slightly annoyed, my colleague complies with this request, answers the questions and sends the letter to the medical officer. After a few days, he receives a negative reply. This annoys the colleague. As he tells the story, he flies into a rage and rants about the fact that there are apparently simple clerks deciding on behalf of the medical officer. This could not go on, he wanted to talk to the medical officer personally.

A colleague agrees with him and reports her annoyance with Spitex prescriptions. She, like most of us, is always receiving testimonials to sign. The colleague reports full of horror that she has to sign cost estimates of over 9000 francs. At one point, he said, he was charged for putting on and taking off compression stockings every day and for applying a compression bandage. Their complaint then led to the fact that the costs turned out almost 3000 francs lower. But the costs are still far too high, he said.

Another colleague adds that she has to sign a lot of BESA forms and her case costs go up because of that. And so case after case followed case.

My approach in these cases is very easy on the nerves. In the first case, I would also have filled out the certificate to the best of my ability and promptly returned it. I would have been surprised about the negative decision, but certainly not annoyed. I would have referred the patient to the patient center so that he could be helped to get justice.

I sign the Spitex regulations, BESA and Rai/RUG certificates without reading them.

Why, you ask? Quite simply: I cannot judge them materially  correctly at all. In fact, the clarification of the need is carried out by specially trained nurses. I therefore only provide a pro forma signature. The dispute about care planning and the resulting costs should be settled by Spitex, health insurance and the patient without me.

Yours sincerely, Josef Widler, M.D.

Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Costs
  • Drug
  • Spitex.ordinances
Previous Article
  • Current studies in a nutshell

Special aspects of osteoporosis treatment

  • Education
  • Geriatrics
  • Nutrition
  • Rheumatology
  • RX
  • Studies
View Post
Next Article
  • Interview with Prof. Heike Bischoff-Ferrari, Zurich

Always supplement calcium combined with vitamin D

  • Geriatrics
  • Interviews
  • Nutrition
  • Prevention and health care
  • RX
View Post
You May Also Like
View Post
  • 7 min
  • Plastic surgery and reconstructive microsurgery for DFS

Functional limb preservation between infection control, vascular medicine and resurfacing

    • RX
    • Angiology
    • CME continuing education
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Geriatrics
    • Physical medicine and rehabilitation
    • Surgery
View Post
  • 12 min
  • SURPASS-CVOT

Tirzepatide versus Dulaglutide in T2D with ASCVD

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Pharmacology and toxicology
    • Studies
View Post
  • 6 min
  • Secondary prevention after ACS: individually optimized lipid management

Trend towards early combination therapy and new strategies for lowering Lp(a)

    • RX
    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • Studies
View Post
  • 27 min
  • Pediatric Brain Tumors

Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls

    • RX
    • CME continuing education
    • Neurology
    • Oncology
    • Pediatrics
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 13 min
  • What the latest studies on the entire EF spectrum mean for clinical practice

Heart Failure – The 2026 Evidence Update

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • Studies
View Post
  • 5 min
  • Acute ischemic stroke

Alteplase and Tenecteplase Are on the Same Level

    • RX
    • Education
    • Emergency and intensive care medicine
    • Neurology
    • Pharmacology and toxicology
    • Studies
View Post
  • 5 min
  • CKD in People with Type 2 Diabetes: Evidence-Based, Optimized Treatment

SGLT-2 inhibitors and GLP-1 receptor agonists: significant improvement in renal outcomes

    • RX
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nephrology
    • Studies
View Post
  • 2 min
  • Wearables: screening via smartwatch?

New study on atrial fibrillation in high-risk patients

    • RX
    • Cardiology
    • Practice Management
    • Prevention and health care
    • Studies
Landingpage Fachinfo Landingpage Button
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.